A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma.

A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma.

August 23, 2025
admin@narisara
0

Research Topics

Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody

Researchers

Dr.Koramit Suppipat

Institute

Multicenter Clinical Trials

Funding

PMU-C

Timeline

2026-2028

Tags: Chulalongkorn University